Neuronetics Inc. (NASDAQ: STIM) Stock Information | RedChip

Neuronetics Inc. (NASDAQ: STIM) Listen to this Section


$1.12
+0.1550 ( +16.06% ) 919.6K

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Market Data


Open


$1.12

Previous close


$0.97

Volume


919.6K

Market cap


$33.93M

Day range


$0.94 - $1.20

52 week range


$0.66 - $5.07

Insider Ownership Transactions

Total Amount Purchased: -607,109.00 | $ -679,962.08

Date Type Amount Purchased Purchaser
2024-02-28 Sale -20292.00 Sullivan Keith J
2024-02-26 Sale -20851.00 Sullivan Keith J
2024-02-22 Sale -23958.00 Sullivan Keith J
2024-02-16 Sale -15621.00 MACAN WILLIAM ANDREW
2024-02-13 Sale -14710.00 Furlong Stephen
2024-02-07 Sale -300000.00 Sullivan Keith J
2024-02-07 Sale -100000.00 Furlong Stephen
2024-02-07 Sale -90000.00 MACAN WILLIAM ANDREW
2024-01-12 Sale -10013.00 Sullivan Keith J
2023-12-21 Sale -11664.00 MACAN WILLIAM ANDREW

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 06, 2024
4 Insider transactions 2 Jun 05, 2024
4 Insider transactions 2 Jun 05, 2024
4 Insider transactions 2 Jun 05, 2024
4 Insider transactions 2 Jun 05, 2024
8-k 8K-related 13 Jun 03, 2024
8-k 8K-related 15 May 07, 2024
10-q Quarterly Reports 83 May 07, 2024
8-k 8K-related 13 May 07, 2024
def Proxies and info statements 6 Apr 11, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.